Owners

Our owners’ contribution to society

By supporting independent research at the highest level, our owners strive to significantly improve people’s health and well-being.

A stable ownership structure

Although traded on the NASDAQ Copenhagen (OMX: ALK B), ALK boasts an unusually stable ownership, with two shareholders having notified shareholdings of 5% or more.

The Lundbeck Foundation is one of the largest enterprise foundations in Denmark with the total market value of its commercial activities estimated at more than DKK 50 billion and an annual spend of minimum DKK 500 million in grants to support biomedical research with a special focus on the brain.

Founded in 1954 by the widow of the founder of the Danish pharmaceutical company, H. Lundbeck A/S, the foundation is the largest and controlling shareholder of ALK, owning 40% of the capital and controlling 67% of the votes.

In addition, the foundation is the majority shareholder of two other large Danish companies, Lundbeck and Falck, and manages securities worth about DKK 22 billion.

Overview of the Lundbeck Foundation

ALK’s controlling shareholder

The Lundbeck Foundation is the largest and controlling shareholder of ALK, owning 40% of the capital and controlling 67% of the votes.

The Foundation’s commercial activities provide a financial stability that underpins its principal stated aim, that of funding research that aims to reduce the rising global burden of psychiatric and neurological diseases.